Company Filing History:
Years Active: 2006
Title: The Innovations of Henricus Antonius Van Veen
Introduction
Henricus Antonius Van Veen is a notable inventor based in Boskoop, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. His work has the potential to impact the treatment of hereditary conditions and improve patient care.
Latest Patents
Henricus Antonius Van Veen holds a patent for a C1 Inhibitor produced in the milk of transgenic non-human mammals. This invention provides a method for producing C1 inhibitors in the milk of transgenic mammals, which can be beneficial for treating patients with hereditary angioedema or those requiring immunosuppression. The patent highlights the innovative approach to utilizing genetic engineering for medical advancements.
Career Highlights
Van Veen is associated with Pharming Intellectual Property Bv, a company focused on developing innovative therapies. His work at Pharming has been instrumental in advancing the field of biopharmaceuticals. With a patent portfolio that includes his groundbreaking invention, he has established himself as a key figure in the biotechnology sector.
Collaborations
Henricus Antonius Van Veen has collaborated with notable colleagues such as Jan Henricus Nuijens and Frank Pieper. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the field.
Conclusion
Henricus Antonius Van Veen's contributions to biotechnology, particularly through his patent for a C1 Inhibitor, demonstrate his commitment to advancing medical science. His work has the potential to significantly improve treatment options for patients with specific health conditions.